[Newsdesk] Research in brieftranslating…

Although observational studies suggest that the four-component meningococcal serogroup B vaccine (4CMenB) might lower the risk of gonorrhoea, the randomised GoGoVax trial in Australia found that 4CMenB vaccination did not result in fewer Neisseria gonorrhoeae infections compared…